Overview Effectiveness, Safety and Tolerability Study of RP-G28 for Symptoms Associated With Lactose Intolerance Status: Completed Trial end date: 2011-12-01 Target enrollment: Participant gender: Summary This is a Phase 2 study designed to assess the ability of RP-G28 to improve lactose digestion and tolerance. Phase: Phase 2 Details Lead Sponsor: Ritter Pharmaceuticals, Inc.